← Back to Analyst Consensus 
NEO Buy
NEOGENOMICS INC
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 2 reiterations from 3 firms
Next Earnings
Oct 28, 2026 (2 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 6, 2026 | StoneX | maintain | Buy → Buy | — | — |
| Oct 6, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Oct 6, 2026 | BTIG | upgrade | Neutral → Buy | — | 52% |
| Jul 29, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 24, 2026 | Benchmark | maintain | Buy → Buy | — | 54% |
| Apr 29, 2026 | Benchmark | upgrade | Hold → Buy | — | 54% |
| Apr 29, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Apr 29, 2026 | Leerink Partners | upgrade | Market Perform → Outperform | — | 51% |
| Feb 24, 2026 | Piper Sandler | maintain | Overweight → Overweight | $13 | 54% |
| Feb 17, 2026 | Needham | maintain | Buy → Buy | $15 | 50% |
| Jan 12, 2026 | Needham | reiterate | Buy → Buy | $14 | 50% |
| Sep 12, 2025 | TD Cowen | maintain | Buy → Buy | $12 | 54% |
| Sep 2, 2025 | Stephens & Co. | maintain | Overweight → Overweight | $11 | 54% |
| Aug 29, 2025 | Needham | maintain | Buy → Buy | $14 | 50% |
| Aug 4, 2025 | Piper Sandler | maintain | Overweight → Overweight | $11 | 54% |
| Jul 30, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $8 | 54% |
| Jul 29, 2025 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Jul 29, 2025 | Needham | maintain | Buy → Buy | $8 | 50% |
| May 6, 2025 | Piper Sandler | maintain | Overweight → Overweight | $12 | 54% |
| May 1, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $10 | 54% |
| Apr 30, 2025 | Goldman Sachs | maintain | Buy → Buy | $10 | 54% |
| Apr 30, 2025 | Leerink Partners | downgrade | Outperform → Market Perform | $9 | 51% |
| Apr 29, 2025 | Needham | maintain | Buy → Buy | $8.5 | 50% |
| Apr 17, 2025 | Goldman Sachs | maintain | Buy → Buy | $15 | 54% |
| Feb 26, 2025 | Piper Sandler | maintain | Overweight → Overweight | $18 | 54% |
| Feb 19, 2025 | B of A Securities | maintain | Neutral → Neutral | $16 | 53% |
| Feb 19, 2025 | Needham | maintain | Buy → Buy | $18 | 50% |
| Jan 28, 2025 | Goldman Sachs | maintain | Buy → Buy | $18 | 54% |
| Jan 16, 2025 | Benchmark | reiterate | Hold → Hold | $0 | 54% |
| Jan 15, 2025 | Needham | reiterate | Buy → Buy | $19 | 50% |
| Jan 13, 2025 | Benchmark | downgrade | Buy → Hold | $0 | 54% |
| Jan 10, 2025 | Needham | reiterate | Buy → Buy | $19 | 50% |
| Dec 13, 2024 | B of A Securities | maintain | Neutral → Neutral | $19 | 53% |
| Dec 10, 2024 | Jefferies | initiate | — → Buy | $22 | 52% |
| Nov 6, 2024 | Needham | reiterate | Buy → Buy | $19 | 50% |
| Sep 25, 2024 | Needham | reiterate | Buy → Buy | $19 | 50% |
| Sep 24, 2024 | Benchmark | reiterate | Buy → Buy | $18 | 54% |
| Jul 30, 2024 | Stephens & Co. | reiterate | Overweight → Overweight | $19 | 54% |
| Jul 30, 2024 | Benchmark | reiterate | Buy → Buy | $18 | 54% |
| Jul 30, 2024 | Needham | reiterate | Buy → Buy | $19 | 50% |
| May 2, 2024 | BTIG | maintain | Buy → Buy | $21 | 52% |
| May 1, 2024 | TD Cowen | maintain | Buy → Buy | $20 | 54% |
| May 1, 2024 | Benchmark | reiterate | Buy → Buy | $18 | 54% |
| Apr 30, 2024 | Needham | maintain | Buy → Buy | $19 | 50% |
| Feb 26, 2024 | Piper Sandler | maintain | Overweight → Overweight | $20 | 54% |
| Feb 22, 2024 | Goldman Sachs | maintain | Buy → Buy | $19 | 54% |
| Feb 21, 2024 | Needham | maintain | Buy → Buy | $24 | 50% |
| Dec 29, 2023 | TD Cowen | maintain | Outperform → Outperform | $19 | 54% |
| Dec 29, 2023 | BTIG | maintain | Buy → Buy | $21 | 52% |
| Dec 28, 2023 | Needham | reiterate | Buy → Buy | $21 | 50% |
Price Target Trend
May 13, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days